Physician profile
Eric A Potts
NPI 1265424543
$345,303.42
in general payments reported to CMS, 2019-2025
10 companies · $60K in 2025
The $60K reported for 2025 was more than what 96% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $37K · 2020: $19K · 2021: $41K · 2022: $41K · 2023: $78K · 2024: $70K · 2025: $60K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $200K · Consulting Fee: $6,950 · Food and Beverage: $644 · Education: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $200,108.00 |
| Consulting Fee | $6,950.00 |
| Food and Beverage | $644.42 |
| Education | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $289,769.14 | 2021-2025 | T2 Stratosphere Expandable Corpectomy System, Verte-Stack Spinal System, Cd Horizon Spinal System |
| Medtronic USA, INC. | $55,177.77 | 2019-2020 | |
| Stryker Corporation | $159.74 | 2019-2020 | |
| Kuros Biosciences USA, INC | $88.78 | 2025 | Magnetos |
| Depuy Synthes Sales INC. | $29.70 | 2020 | |
| Zimmer Biomet Holdings, INC. | $22.73 | 2023 | Ti Rapidflap Spindown |
| Vertex Pharmaceuticals Incorporated | $22.23 | 2025 | |
| Csl Behring | $20.00 | 2024 | Kcentra |
| Centinel Spine, LLC | $13.33 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Potts listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.